UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Association between HLA‐B1502 and carbamazepine‐induced severe cutaneous adverse drug reactions in a Thai population

Epilepsia (Copenhagen), 2010-05, Vol.51 (5), p.926-930

2010

Volltextzugriff (PDF)

Retrospective analysis of Stevens–Johnson syndrome and toxic epidermal necrolysis in 87 Japanese patients – Treatment and outcome

Allergology International, 2016-01, Vol.65 (1), p.74-81

2016

Volltextzugriff (PDF)

HLA‐B alleles associated with severe cutaneous reactions to antiepileptic drugs in Han Chinese

Epilepsia (Copenhagen), 2013-07, Vol.54 (7), p.1307-1314

2013

Volltextzugriff (PDF)

Stevens‐Johnson syndrome and toxic epidermal necrolysis with antiepileptic drugs: An analysis of the US Food and Drug Administration Adverse Event Reporting System

Epilepsia (Copenhagen), 2018-12, Vol.59 (12), p.2318-2324

2018

Volltextzugriff (PDF)

In vitro drug causality assessment in Stevens-Johnson syndrome - alternatives for lymphocyte transformation test

Clinical and experimental allergy, 2013-09, Vol.43 (9), p.1027-1037

2013

Volltextzugriff (PDF)

U.K. guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults 2016

British journal of dermatology (1951), 2016-06, Vol.174 (6), p.1194-1227

2016

Volltextzugriff (PDF)

Pristinamycin‐induced toxic epidermal necrolysis: A case report

British journal of clinical pharmacology, 2024-08, Vol.90 (8), p.1869-1872

2024

Volltextzugriff (PDF)

Carbamazepine and phenytoin induced Stevens‐Johnson syndrome is associated with HLA‐B1502 allele in Thai population

Epilepsia (Copenhagen), 2008-12, Vol.49 (12), p.2087-2091

2008

Volltextzugriff (PDF)

Association between HLA‐B1502 Allele and Antiepileptic Drug‐Induced Cutaneous Reactions in Han Chinese

Epilepsia (Copenhagen), 2007-05, Vol.48 (5), p.1015-1018

2007

Volltextzugriff (PDF)

Genetic and clinical risk factors associated with phenytoin‐induced cutaneous adverse drug reactions in Thai population

Pharmacoepidemiology and drug safety, 2020-05, Vol.29 (5), p.565-574

2020

Volltextzugriff (PDF)

A case of eruptive lichen spinulosus after toxic epidermal necrolysis

Pediatric dermatology, 2023-03, Vol.40 (2), p.398-400

2023

Volltextzugriff (PDF)

Association of HLA-B1502 allele with carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome in the multi-ethnic Malaysian population

International journal of dermatology, 2011-02, Vol.50 (2), p.221-224

2011

Volltextzugriff (PDF)

Retrospective review of drug‐induced Stevens‐Johnson syndrome and toxic epidermal necrolysis cases at a pediatric tertiary care institution

Pediatric dermatology, 2020-05, Vol.37 (3), p.461-466

2020

Volltextzugriff (PDF)

Long‐term complications of Stevens–Johnson syndrome/toxic epidermal necrolysis (SJS/TEN): the spectrum of chronic problems in patients who survive an episode of SJS/TEN necessitates multidisciplinary follow‐up

British journal of dermatology (1951), 2017-10, Vol.177 (4), p.924-935

2017

Volltextzugriff (PDF)

A novel multiplex polymerase chain reaction assay for detection of both HLA‐A31:01/HLA‐B15:02 alleles, which confer susceptibility to carbamazepine‐induced severe cutaneous adverse reactions

HLA, 2017-12, Vol.90 (6), p.335-342

2017

Volltextzugriff (PDF)

Open trial of ciclosporin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis

British journal of dermatology (1951), 2010-10, Vol.163 (4), p.847-853

2010

Volltextzugriff (PDF)

An extremely rare mucocutaneous adverse reaction following COVID‐19 vaccination: Toxic epidermal necrolysis

Dermatologic therapy, 2022-05, Vol.35 (5), p.e15416-n/a

2022

Volltextzugriff (PDF)

Clinical Pharmacogenetics Implementation Consortium Guidelines for Human Leukocyte Antigen-B Genotype and Allopurinol Dosing

Clinical pharmacology and therapeutics, 2013-02, Vol.93 (2), p.153-158

2013

Volltextzugriff (PDF)

HLA Class I markers in Japanese patients with carbamazepine‐induced cutaneous adverse reactions

Epilepsia (Copenhagen), 2010-02, Vol.51 (2), p.297-300

2010

Volltextzugriff (PDF)

Severe cutaneous adverse drug reactions: Incidence, clinical patterns, causative drugs and modalities of treatment in Assiut University Hospital, Upper Egypt

Dermatologic therapy, 2020-11, Vol.33 (6), p.e14176-n/a

2020

Volltextzugriff (PDF)

Pediatric toxic epidermal necrolysis treated successfully with infliximab

Pediatric dermatology, 2019-05, Vol.36 (3), p.342-345

2019

Volltextzugriff (PDF)

Pharmacogenetics of cutaneous adverse drug reactions

Journal of dermatology, 2011-03, Vol.38 (3), p.246-254

AIHARA, Michiko

2011

Volltextzugriff (PDF)

Incidence rates of severe cutaneous adverse reactions due to antiseizure medication: A nationwide study using health claims data in Korea

Epilepsia (Copenhagen), 2021-01, Vol.62 (1), p.250-257

2021

Volltextzugriff (PDF)

Ethosuximide‐induced Stevens‐Johnson syndrome/toxic epidermal necrolysis overlap confirmed by patch testing in a child

Contact dermatitis, 2021-11, Vol.85 (5), p.602-604

2021

Volltextzugriff (PDF)

Cochrane corner: Systemic interventions for treatment of Stevens‐Johnson syndrome (SJS), toxic epidermal necrolysis (TEN) and SJS/TEN overlap syndrome

Clinical and experimental allergy, 2022-11, Vol.52 (11), p.1244-1246

2022

Volltextzugriff (PDF)

1 – 25 von 1.079

Suche als RSS-Feed

Aktive Filter

KollektionWiley Online Library Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.035)
Mit Volltextzugriff
(989)

Publikationsform

Sprache

Englisch
(1.066)
Deutsch
(12)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(933)
Science & Technology
(886)
Life Sciences & Biomedicine
(885)
Dermatology
(604)
Female
(489)
Male
(449)
Stevens-Johnson Syndrome - Etiology
(346)
Toxic Epidermal Necrolysis
(339)
Adult
(333)
Middle Aged
(296)
Stevens-Johnson Syndrome
(284)
Aged
(220)
Biological And Medical Sciences
(218)
Medical Sciences
(218)
Stevens-Johnson Syndrome - Diagnosis
(206)
Stevens-Johnson Syndrome - Pathology
(178)
Child
(175)
Stevens-Johnson Syndrome - Drug Therapy
(153)
Adolescent
(147)
Skin Diseases
(135)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Association between HLA‐B1502 and carbamazepine‐induced severe cutaneous adverse drug reactions in a Thai population

Retrospective analysis of Stevens–Johnson syndrome and toxic epidermal necrolysis in 87 Japanese patients – Treatment and outcome

HLA‐B alleles associated with severe cutaneous reactions to antiepileptic drugs in Han Chinese

Stevens‐Johnson syndrome and toxic epidermal necrolysis with antiepileptic drugs: An analysis of the US Food and Drug Administration Adverse Event Reporting System

In vitro drug causality assessment in Stevens-Johnson syndrome - alternatives for lymphocyte transformation test

U.K. guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults 2016

Pristinamycin‐induced toxic epidermal necrolysis: A case report

Carbamazepine and phenytoin induced Stevens‐Johnson syndrome is associated with HLA‐B1502 allele in Thai population

Association between HLA‐B1502 Allele and Antiepileptic Drug‐Induced Cutaneous Reactions in Han Chinese

Genetic and clinical risk factors associated with phenytoin‐induced cutaneous adverse drug reactions in Thai population

A case of eruptive lichen spinulosus after toxic epidermal necrolysis

Association of HLA-B1502 allele with carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome in the multi-ethnic Malaysian population

Retrospective review of drug‐induced Stevens‐Johnson syndrome and toxic epidermal necrolysis cases at a pediatric tertiary care institution

Long‐term complications of Stevens–Johnson syndrome/toxic epidermal necrolysis (SJS/TEN): the spectrum of chronic problems in patients who survive an episode of SJS/TEN necessitates multidisciplinary follow‐up

A novel multiplex polymerase chain reaction assay for detection of both HLA‐A31:01/HLA‐B15:02 alleles, which confer susceptibility to carbamazepine‐induced severe cutaneous adverse reactions

Open trial of ciclosporin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis

An extremely rare mucocutaneous adverse reaction following COVID‐19 vaccination: Toxic epidermal necrolysis

Clinical Pharmacogenetics Implementation Consortium Guidelines for Human Leukocyte Antigen-B Genotype and Allopurinol Dosing

HLA Class I markers in Japanese patients with carbamazepine‐induced cutaneous adverse reactions

Severe cutaneous adverse drug reactions: Incidence, clinical patterns, causative drugs and modalities of treatment in Assiut University Hospital, Upper Egypt

Pediatric toxic epidermal necrolysis treated successfully with infliximab

Pharmacogenetics of cutaneous adverse drug reactions

Incidence rates of severe cutaneous adverse reactions due to antiseizure medication: A nationwide study using health claims data in Korea

Ethosuximide‐induced Stevens‐Johnson syndrome/toxic epidermal necrolysis overlap confirmed by patch testing in a child

Cochrane corner: Systemic interventions for treatment of Stevens‐Johnson syndrome (SJS), toxic epidermal necrolysis (TEN) and SJS/TEN overlap syndrome

Aktive Filter

Suchergebnisse filtern